FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2018/08/015373 [Registered on: 17/08/2018] Trial Registered Prospectively
Last Modified On: 07/12/2018
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Unani 
Study Design  Single Arm Study 
Public Title of Study   Treatment of Non bleeding piles with Unani Medicine Habb-e-Bawaseer Amya. 
Scientific Title of Study   Clinical Validation of Unani Pharmacopoeal formulation Habb-e-Bawaseer Amya in Bawaseer Amya (Non bleeding piles) 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
BD/NBP/HBD/CLN-VAL/CCRUM 16-17 version 1, 26.03.17  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Naheed Parveen 
Designation  Assistant Director (Unani) 
Affiliation  Central Council for Research in Unani Medicine (CCRUM) 
Address  Room No 507 Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri

South West
DELHI
110058
India 
Phone    
Fax    
Email  ccrum507@rediffmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Naheed Parveen 
Designation  Assistant Director (Unani) 
Affiliation  Central Council for Research in Unani Medicine (CCRUM) 
Address  Room No 507 Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri

South West
DELHI
110058
India 
Phone    
Fax    
Email  ccrum507@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Pradeep Kumar 
Designation  Research Officer (Path) SIV 
Affiliation  Central Council for Research in Unani Medicine (CCRUM) 
Address  Room No 516 Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri

South West
DELHI
110058
India 
Phone    
Fax    
Email  drpradeepkumar2001@yahoo.com  
 
Source of Monetary or Material Support  
Infrastructural support : 1 Regional Research Institute of Unani Medicine Mumbai 2. Regional Research Institute of Unani Medicine Chennai 3 Regional Research Centre Allahabad Monetary Support: Central Council For Research In Unani Medicine, Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri New Delhi 110058 
 
Primary Sponsor  
Name  Central Council For Research In Unani Medicine 
Address  Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri South West DELHI 110058 India 
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 3  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ashok Kumar  Regional Research Centre  Research OPD Room Bawaseer Amya (Non bleeding piles) B-501/4, G T B Nagar (Opposite Dulhan Palace)
Allahabad
UTTAR PRADESH 
9450619024

rrcallahabad@gmail.com 
Dr Irfan Ahmad  Regional Research Institute of Unani Medicine  Research OPD Room Bawaseer Amya (Non bleeding piles) Behind Eye Bank, Sir J J Hospital Compound, Byculla
Mumbai
MAHARASHTRA 
9987427379

irfanmumbai8@gmail.com 
Dr Mrs T Shahida Begum  Regional Research Institute of Unani Medicine  Research OPD Room Bawaseer Amya (Non bleeding piles) 1, West Madha Church Road, Royapuram
Chennai
TAMIL NADU 
04425955519

tshahidabegum@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 3  
Name of Committee  Approval Status 
Regional Research Centre Allahabad  Approved 
Regional Research Institute of Unani Medicine Chennai  Approved 
Regional Research Institute of Unani Medicine Mumbai  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied
Modification(s)  
Health Type  Condition 
Patients  Bawaseer Amya (Non bleeding piles), (1) ICD-10 Condition: K640||First degree hemorrhoids,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Habb-e-Bawaseer Umiyya  Habb-e-Bawaseer Umiyya, 1 Pill (250 mg ) orally Twice daily with water one hour after meals for two weeks  
Comparator Agent  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1. Patients of either sex in the age group 18 to 65 years
2. Patients diagnosed with Bawāsīr Umiyya (Non-bleeding Piles) presenting with any of the following symptoms:
(i) Mucoid Anal/ Perianal Discharge (Sayalān al-Maq‘ad Mukhātī): mucus discharge
(ii) Pruritus Ani (Hikka al-Maq‘ad)
(iii) Mucosal Prolapse (Khurūj al-Mukhātīyya) with Spontaneous Reduction
(iv) Rectal/ Anal Pain (Waja‘ al-Maq‘ad)
 
 
ExclusionCriteria 
Details  The following patients will be excluded from the study:
1. Patients with Bawaseer Damiya (Bleeding piles).
2. Patients with Fourth Degree Haemorrhoids (irreducible prolapse)
3. Known cases of Anal fissure, anal fistula and other surgical conditions of the anus.
4. Known cases of other clinically significant co-morbid conditions (severe hepatic, renal, cardiovascular disorders, etc)
5. Patients with Inflammatory Bowel Disorders (Positive Haemoccult Test)
6. Pregnant and Lactating Women
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Improvement in signs and symptoms of Bawaseer Amya (Non bleeding piles)  Two Weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Haematological and biochemical assessment for safety assessment   Two weeks 
 
Target Sample Size   Total Sample Size="300"
Sample Size from India="300" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   21/08/2018 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   None yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   his study is a multicentric open trial in patients with Bawaseer Amya (Non bleeding piles)  After screening, Patients will be enrolled if they satisfy inclusion and exclusion criteria.  The patients will be assessed clinically on Baseline,and after two  weeks.  This includes subjective assessment of general well being and physical examination . The total duration of treatment will be fourteen days. Laboratory parameters for safety assessment will be conducted at baseline and on completion of the protocol therapy

Composition of Habb-e-Bawaseer Damiya (Anonymous, 2006)

S. No.

Ingredients

Botanical / English Name

Quantity

  1.  

Rasaut

Berberis aristata DC.

100 g

  1.  

Halela Kabli Biryan

Terminalia chebula Retz.

100 g

  1.  

Raughan Zard

Cow’s Ghee

Q.S.

 
Close